North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
about
Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.Formal thought disorder in people at ultra-high risk of psychosis.Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis.Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.A Longitudinal Study of Violent Behavior in a Psychosis-Risk Cohort.Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.Polish individuals with an at-risk mental state: demographic and clinical characteristics.Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis.Emergent, remitted and persistent psychosis-spectrum symptoms in 22q11.2 deletion syndrome.Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genesPerceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety.Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.Comorbid diagnoses for youth at clinical high risk of psychosis.Neuroanatomical and Symptomatic Sex Differences in Individuals at Clinical High Risk for Psychosis.A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China.Premorbid social adjustment and association with attenuated psychotic symptoms in clinical high-risk and help-seeking youth.Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis.Prediction of psychosis across protocols and risk cohorts using automated language analysis.Abnormal relationships between local and global brain measures in subjects at clinical high risk for psychosis: a pilot study.The search for imaging biomarkers in psychiatric disorders.Distinct Relationships Between Visual and Auditory Perceptual Abnormalities and Conversion to Psychosis in a Clinical High-Risk Population.Attenuated first-rank symptoms and conversion to psychosis in a clinical high-risk cohort.Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.Motor Dysfunction as a Risk Factor for Conversion to Psychosis Independent of Medication Use in a Psychosis-Risk Cohort.The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
P2860
Q33814290-BD973A7B-2D15-4CB3-BF00-43D990492288Q33903488-2C3C8F2A-05C4-4731-8653-E9AEFDB7996EQ37124956-B3357F26-DAD2-46FB-B352-7C372334E274Q37285496-ED0E323B-EC0E-42BC-95F4-5B979A2CFEB3Q38651635-52A8755B-AB2B-46C1-9142-BEEE3A846862Q39223781-342AA920-B806-42A9-9194-8C6F7ACCB420Q39231447-899067BB-6408-47E8-A8FC-49581D0B797EQ39824871-D08FE2A3-5ABD-4F31-BB17-4074747B0404Q40925457-E96D6722-0746-4790-9AEE-2F10E5B730F2Q41197083-AC75A4A1-39B1-4635-8634-3C4735426957Q42257168-368C5C27-4B53-4DF7-B502-17E3D3838F7DQ46028828-59E0F723-D63D-4E70-B0D4-A46BFC1B156FQ46228189-A59532A1-7968-4A81-B9C7-512871D183B1Q46819894-CC423538-E8A6-4882-893A-8F059BF4C731Q47192316-692DBB0A-F847-4F44-AF60-2F6A9354DE43Q47233520-012EBFA7-F4C7-4A43-B288-945D0B4C8BB3Q47298915-090B755D-ADF4-4152-BD2F-8F65F776FB63Q47316102-DA20986E-236A-42EA-B68F-56B596D48281Q47553771-3D2B73D5-AC01-4080-B313-D20F188823B5Q47644727-1D1A34ED-C80F-4E03-924A-AED61C674420Q47895140-C1665F0C-4D81-4959-BA3A-BD7447E57419Q49277035-88DCAF63-C41D-418C-A8D8-4DEDAD7E2A3AQ49910444-2577B8D0-48BE-4830-9C74-01B99A31631EQ50533618-70CF58E0-3FB0-4070-9AE1-0A8213FF4D55Q52645310-1CE8F00F-45D5-49DF-B6A2-DDB9A1B3B638Q55383317-8E20A7E0-C3D0-4370-98D0-1398668FFCA8
P2860
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@ast
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@en
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@nl
type
label
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@ast
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@en
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@nl
prefLabel
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@ast
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@en
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@nl
P2093
P2860
P50
P1476
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms
@en
P2093
Barbara A. Cornblatt
Carrie E. Bearden
Daniel H. Mathalon
Diana O. Perkins
Elaine F. Walker
Lisa Buchy
Ming T. Tsuang
Scott W. Woods
P2860
P304
P356
10.1097/NMD.0000000000000290
P407
P577
2015-05-01T00:00:00Z